HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

L. Altice, Frederick; Douglas Bruce, R.; M. Lucas, Gregory; J. Lum, Paula; Todd Korthuis, P.; Flanigan, Timothy; O. Cunningham, Chinazo; E. Sullivan, Lynn; Vergara‐Rodriguez, Pamela; A. Fiellin, David; Cajina, Adan; Botsko, Michael; Nandi, Vijay; N. Gourevitch, Marc; Finkelstein, Ruth

doi:10.1097/qai.0b013e318209751e

Public

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

Published in JAIDS Journal of Acquired Immune Deficiency Syndromes • Feb 11, 2011

Authors:

Frederick L. Altice

R. Douglas Bruce

Gregory M. Lucas

Abstract

BACKGROUND: Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes. METHODS: HIV-infected, opioid-dependent subjects (N = 295) recruited from 10 clinical sites initiated buprenorphine/naloxone (BUP/NX) and were assessed at baseline and quarterly for 12 mon...

Subject

Medicine

Buprenorphine

(+)-Naloxone

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!